Ledger.Open graph →
SEC Form D · filed January 13, 2021

ONCOQUEST PHARMA USA, INC

Offering
$510K
Sold
$510K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MIRYANG SI, GYEONGSANGNAMDO, M5
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Ragupathy Madiyalakan · Edmonton, Alberta, CanadaExec · DirectorKarthik Radhakrishnan · The Woodlands, TXExec · DirectorLyn Lim · MIRYANG SI, GYEONGSANGNAMDO, M5DirectorAlex Jung · MIRYANG SI, GYEONGSANGNAMDO, M5Exec · DirectorKarthik Radhakrishnan · The Woodlands, TXExec · DirectorRagupathy Madiyalakan · Edmonton, Alberta, CanadaExec · DirectorLyn Lim · MIRYANG SI, GYEONGSANGNAMDO, M5DirectorAlex Jung · MIRYANG SI, GYEONGSANGNAMDO, M5Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗